391 related articles for article (PubMed ID: 34893352)
1. Pathogenic insights from genetic causes of autoinflammatory inflammasomopathies and interferonopathies.
Lin B; Goldbach-Mansky R
J Allergy Clin Immunol; 2022 Mar; 149(3):819-832. PubMed ID: 34893352
[TBL] [Abstract][Full Text] [Related]
2. Lung Inflammation in STING-Associated Vasculopathy with Onset in Infancy (SAVI).
David C; Frémond ML
Cells; 2022 Jan; 11(3):. PubMed ID: 35159128
[TBL] [Abstract][Full Text] [Related]
3. Toward a better understanding of type I interferonopathies: a brief summary, update and beyond.
Yu ZX; Song HM
World J Pediatr; 2020 Feb; 16(1):44-51. PubMed ID: 31377974
[TBL] [Abstract][Full Text] [Related]
4. Insights from Mendelian Interferonopathies: Comparison of CANDLE, SAVI with AGS, Monogenic Lupus.
Kim H; Sanchez GA; Goldbach-Mansky R
J Mol Med (Berl); 2016 Oct; 94(10):1111-1127. PubMed ID: 27678529
[TBL] [Abstract][Full Text] [Related]
5. Rare hereditary autoinflammatory disorders: towards an understanding of critical in vivo inflammatory pathways.
Kanazawa N
J Dermatol Sci; 2012 Jun; 66(3):183-9. PubMed ID: 22336993
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and Safety of Janus Kinase Inhibitors in Type I Interferon-Mediated Monogenic Autoinflammatory Disorders: A Scoping Review.
Gómez-Arias PJ; Gómez-García F; Hernández-Parada J; Montilla-López AM; Ruano J; Parra-Peralbo E
Dermatol Ther (Heidelb); 2021 Jun; 11(3):733-750. PubMed ID: 33856640
[TBL] [Abstract][Full Text] [Related]
7. The expanding pathways of autoinflammation: a lesson from the first 100 genes related to autoinflammatory manifestations.
Papa R; Picco P; Gattorno M
Adv Protein Chem Struct Biol; 2020; 120():1-44. PubMed ID: 32085880
[TBL] [Abstract][Full Text] [Related]
8. [Type I interferonopathies].
Munoz J; Marque M; Dandurand M; Meunier L; Crow YJ; Bessis D
Ann Dermatol Venereol; 2015 Nov; 142(11):653-63. PubMed ID: 26363997
[TBL] [Abstract][Full Text] [Related]
9. Monogenic autoinflammatory diseases: Cytokinopathies.
Moghaddas F; Masters SL
Cytokine; 2015 Aug; 74(2):237-46. PubMed ID: 25814341
[TBL] [Abstract][Full Text] [Related]
10. Biologics and JAK inhibitors for the treatment of monogenic systemic autoinflammatory diseases in children.
Du Y; Liu M; Nigrovic PA; Dedeoglu F; Lee PY
J Allergy Clin Immunol; 2023 Mar; 151(3):607-618. PubMed ID: 36707349
[TBL] [Abstract][Full Text] [Related]
11. Contribution of the Unfolded Protein Response (UPR) to the Pathogenesis of Proteasome-Associated Autoinflammatory Syndromes (PRAAS).
Ebstein F; Poli Harlowe MC; Studencka-Turski M; Krüger E
Front Immunol; 2019; 10():2756. PubMed ID: 31827472
[TBL] [Abstract][Full Text] [Related]
12. Genetic interferonopathies: An overview.
Eleftheriou D; Brogan PA
Best Pract Res Clin Rheumatol; 2017 Aug; 31(4):441-459. PubMed ID: 29773266
[TBL] [Abstract][Full Text] [Related]
13. An Update on Autoinflammatory Diseases: Inflammasomopathies.
Harapas CR; Steiner A; Davidson S; Masters SL
Curr Rheumatol Rep; 2018 May; 20(7):40. PubMed ID: 29846819
[TBL] [Abstract][Full Text] [Related]
14. Monogenic autoinflammatory disorders: Conceptual overview, phenotype, and clinical approach.
Nigrovic PA; Lee PY; Hoffman HM
J Allergy Clin Immunol; 2020 Nov; 146(5):925-937. PubMed ID: 33160483
[TBL] [Abstract][Full Text] [Related]
15. Gain of function mutation and inflammasome driven diseases in human and mouse models.
Cordero MD; Alcocer-Gómez E; Ryffel B
J Autoimmun; 2018 Jul; 91():13-22. PubMed ID: 29610014
[TBL] [Abstract][Full Text] [Related]
16. Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases.
de Jesus AA; Hou Y; Brooks S; Malle L; Biancotto A; Huang Y; Calvo KR; Marrero B; Moir S; Oler AJ; Deng Z; Montealegre Sanchez GA; Ahmed A; Allenspach E; Arabshahi B; Behrens E; Benseler S; Bezrodnik L; Bout-Tabaku S; Brescia AC; Brown D; Burnham JM; Caldirola MS; Carrasco R; Chan AY; Cimaz R; Dancey P; Dare J; DeGuzman M; Dimitriades V; Ferguson I; Ferguson P; Finn L; Gattorno M; Grom AA; Hanson EP; Hashkes PJ; Hedrich CM; Herzog R; Horneff G; Jerath R; Kessler E; Kim H; Kingsbury DJ; Laxer RM; Lee PY; Lee-Kirsch MA; Lewandowski L; Li S; Lilleby V; Mammadova V; Moorthy LN; Nasrullayeva G; O'Neil KM; Onel K; Ozen S; Pan N; Pillet P; Piotto DG; Punaro MG; Reiff A; Reinhardt A; Rider LG; Rivas-Chacon R; Ronis T; Rösen-Wolff A; Roth J; Ruth NM; Rygg M; Schmeling H; Schulert G; Scott C; Seminario G; Shulman A; Sivaraman V; Son MB; Stepanovskiy Y; Stringer E; Taber S; Terreri MT; Tifft C; Torgerson T; Tosi L; Van Royen-Kerkhof A; Wampler Muskardin T; Canna SW; Goldbach-Mansky R
J Clin Invest; 2020 Apr; 130(4):1669-1682. PubMed ID: 31874111
[TBL] [Abstract][Full Text] [Related]
17. Monogenic Autoinflammatory Diseases: State of the Art and Future Perspectives.
Di Donato G; d'Angelo DM; Breda L; Chiarelli F
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34198614
[TBL] [Abstract][Full Text] [Related]
18. STING palmitoylation as a therapeutic target.
Hansen AL; Mukai K; Schopfer FJ; Taguchi T; Holm CK
Cell Mol Immunol; 2019 Mar; 16(3):236-241. PubMed ID: 30796349
[TBL] [Abstract][Full Text] [Related]
19. Type I Interferonopathies: from a Novel Concept to Targeted Therapeutics.
Melki I; Frémond ML
Curr Rheumatol Rep; 2020 Jun; 22(7):32. PubMed ID: 32548765
[TBL] [Abstract][Full Text] [Related]
20. Molecular biology of autoinflammatory diseases.
Masumoto J; Zhou W; Morikawa S; Hosokawa S; Taguchi H; Yamamoto T; Kurata M; Kaneko N
Inflamm Regen; 2021 Oct; 41(1):33. PubMed ID: 34635190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
